Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion

27Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Autologous blood transfusion is a powerful means of improving performance and remains one of the most challenging methods to detect. Recent investigations have identified 3 candidate reticulocytes genes whose expression was significantly influenced by blood transfusion. Using quantitative reverse transcription polymerase chain reaction as an alternative quantitative method, the present study supports that delta-aminolevulinate synthase 2 (ALAS2), carbonic anhydrase (CA1), and solute carrier family 4 member 1 (SLC4A1) genes are down-regulated post-transfusion. The expression of these genes exhibited stronger correlation with immature reticulocyte fraction than with reticulocytes percentage. Moreover, the repression of reticulocytes' gene expression was more pronounced than the diminution of immature reticulocyte fraction and reticulocyte percentage following blood transfusion. It suggests that the 3 candidate genes are reliable predictors of bone marrow's response to blood transfusion and that they represent potential biomarkers for the detection of this method prohibited in sports.

Author supplied keywords

Cite

CITATION STYLE

APA

Salamin, O., Mignot, J., Kuuranne, T., Saugy, M., & Leuenberger, N. (2018). Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion. Drug Testing and Analysis, 10(3), 604–608. https://doi.org/10.1002/dta.2240

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free